Finkenzeller T, Techert J, Lenhart M, Link J, Feuerbach S
Abteilung Röntgendiagnostik, Klinikum der Universität Regensburg, Germany.
Rofo. 2001 Oct;173(10):920-3. doi: 10.1055/s-2001-17588.
CT-guided thoracal sympathicolysis for the treatment of peripheral arterial occlusive disease and chronic thoracal pain syndromes in 6 patients.
Retrospective evaluation of the safety and effectivity of CT-guided percutaneous thoracal sympathicolysis (CT-TSL) in the treatment of patients with peripheral arterial occlusive disease (PAOD) of the upper limb and chronic thoracal pain syndromes. Comparison of our own experience with literature reports.
Between 6/96 and 12/99, 4 patients with PAOD of the upper limb and two with chronic thoracal pain syndromes caused by herpes zoster were treated by unilateral CT-TSL.
18, 21 and 32 months after the intervention 3 out of 4 patients treated for PAOD reported subjective improvements, and one remained unchanged. Two patients treated for pain syndromes showed no long-term benefit of the procedure. There were no serious complications.
The CT-TSL is an alternative method in the treatment of PAOD in patients who are unsuitable for treatment by revascularization.
对6例患者进行CT引导下胸交感神经溶解术治疗周围动脉闭塞性疾病和慢性胸痛综合征。
回顾性评估CT引导下经皮胸交感神经溶解术（CT-TSL）治疗上肢周围动脉闭塞性疾病（PAOD）和慢性胸痛综合征患者的安全性和有效性。将我们自己的经验与文献报道进行比较。
在1996年6月至1999年12月期间，对4例上肢PAOD患者和2例由带状疱疹引起的慢性胸痛综合征患者进行了单侧CT-TSL治疗。
在干预后18、21和32个月，4例接受PAOD治疗的患者中有3例报告主观症状改善，1例无变化。2例接受疼痛综合征治疗的患者未显示该手术的长期益处。无严重并发症。
CT-TSL是治疗不适合血管重建治疗的PAOD患者的一种替代方法。
